Loading...
XSHG600993
Market cap1.46bUSD
Jan 09, Last price  
24.82CNY
1D
-0.44%
1Q
-2.05%
Jan 2017
24.29%
Name

Mayinglong Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
XSHG:600993 chart
P/E
24.14
P/S
3.41
EPS
1.03
Div Yield, %
1.41%
Shrs. gr., 5y
0.03%
Rev. gr., 5y
7.38%
Revenues
3.14b
-11.20%
370,989,893411,790,536535,599,394548,633,980809,630,9701,021,983,3551,178,494,5801,415,545,1801,542,034,4511,602,282,4771,620,801,1911,783,682,3522,102,806,8951,750,592,3932,197,507,4932,705,396,2432,791,591,9483,385,059,2553,532,379,0373,136,746,407
Net income
443m
-7.38%
52,636,91160,060,14671,871,238133,403,76180,429,493180,081,085122,538,058137,726,001173,798,448186,324,387201,477,739223,256,086250,243,913320,051,428176,207,926359,967,239419,058,020464,591,713478,571,950443,250,935
CFO
622m
+81.87%
54,191,38458,434,71975,271,3996,485,044102,586,327216,112,501075,366,404169,253,825129,939,557111,670,948182,850,576239,599,870356,168,369308,243,561491,584,397282,988,369597,171,048341,852,836621,742,939
Dividend
Jul 26, 20240.4 CNY/sh

Profile

Mayinglong Pharmaceutical Group Co., LTD. engages in the manufacture, wholesale, and retail of pharmaceutical products primarily in China. It offers hemorrhoid, gynecological, cough, skin, functional food, and Chinese medicine drink tablet products, as well as medical devices. The company also sells its products online. It also operates hospitals. Mayinglong Pharmaceutical Group Co., LTD. was founded in 1582 and is based in Wuhan, China.
URL
https://www.mayinglong.cn/index.html
IPO date
May 17, 2004
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
3,136,746
-11.20%
3,532,379
4.35%
Cost of revenue
2,413,510
2,928,564
Unusual Expense (Income)
NOPBT
723,237
603,815
NOPBT Margin
23.06%
17.09%
Operating Taxes
72,864
78,826
Tax Rate
10.07%
13.05%
NOPAT
650,373
524,990
Net income
443,251
-7.38%
478,572
3.01%
Dividends
(150,869)
(150,869)
Dividend yield
1.45%
1.55%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
45,800
116,231
Long-term debt
287,173
644,000
Deferred revenue
27,891
26,950
Other long-term liabilities
56,350
29,540
Net debt
(2,807,950)
(2,407,700)
Cash flow
Cash from operating activities
621,743
341,853
CAPEX
(248,364)
Cash from investing activities
448,271
Cash from financing activities
(579,165)
178,177
FCF
724,926
402,485
Balance
Cash
3,051,381
3,167,931
Long term investments
89,542
Excess cash
2,984,086
2,991,312
Stockholders' equity
3,819,911
3,521,626
Invested Capital
1,181,556
1,161,585
ROIC
55.51%
49.47%
ROCE
17.24%
14.53%
EV
Common stock shares outstanding
430,341
431,054
Price
24.18
6.99%
22.60
-21.42%
Market cap
10,405,638
6.81%
9,741,818
-21.42%
EV
7,729,625
7,456,738
EBITDA
803,800
682,325
EV/EBITDA
9.62
10.93
Interest
16,659
11,688
Interest/NOPBT
2.30%
1.94%